Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
SNY
Stock Latest News
Ratings
Sanofi’s Promising Growth Prospects: Buy Rating Backed by Brivekimig and Tolebrutinib Potential
4h ago
SNY
Premium
The Fly
Trump Weekly: Trump signs pharma order, FTC opens inquiry into AI chatbots
5d ago
DV
ES
Premium
The Fly
Advertising, drugmaker stocks in spotlight as Trump moves to regulate pharma ads
7d ago
DV
AZN
Premium
The Fly
Omnicom, WPP under pressure after Trump moves to regulate pharma ads
7d ago
AZN
BMY
Premium
The Fly
Trump Trade: U.S. President signs new pharma order
7d ago
DV
AZN
Premium
The Fly
Trump signs memorandum mandating pharma ads give more info on risks
8d ago
AZN
BMY
Premium
Ratings
Sanofi’s Amlitelimab: Buy Rating Amid Challenges and Opportunities in Atopic Dermatitis Market
9d ago
SNY
Premium
The Fly
Sanofi upgraded to Overweight from Equal Weight at Morgan Stanley
9d ago
SNY
Premium
Market News
Morning News Wrap-Up: Friday’s Biggest Stock Market Stories!
11d ago
AMD
DAL
Premium
Market News
Sanofi Stock (SNY) Revives after Trial Miss as Analyst Hails ‘Buying Opportunity’
12d ago
SNY
Premium
The Fly
Sanofi’s ‘disappointing’ atopic dermatitis data sends Nektar higher
13d ago
SNY
AMGN
Premium
Company Announcements
Sanofi’s Amlitelimab Shows Promising Results in Atopic Dermatitis Study
13d ago
6K
SNY
Premium
The Fly
Piper says competitor AD data reinforces Nektar’s REZPEG differentiated profile
13d ago
SNY
NKTR
Premium
The Fly
Salesforce slides, Figma flops after earnings: Morning Buzz
13d ago
AI
GS
Premium
The Fly
Video: Regeneron getting boost from competitor ‘disappointing’ data
13d ago
SNY
REGN
Premium
The Fly
Sanofi’s ‘disappointing’ results to boost Regeneron shares, says Raymond James
13d ago
SNY
AMGN
Premium
The Fly
Nektar jumps after Sanofi data misses expectations
13d ago
SNY
NKTR
Premium
The Fly
Sanofi amlitelimab data ‘well short of investor expectations,’ says BofA
13d ago
SNY
Premium
The Fly
Sanofi says amlitelimab met primary, key secondary endpoints in Phase 3 study
13d ago
SNY
Premium
The Fly
Florida surgeon general says state will eliminate vaccine mandates
14d ago
GSK
PFE
Premium
Company Announcements
Sanofi’s Wayrilz Gains FDA Approval as First BTK Inhibitor for ITP
14d ago
6K
SNY
Premium
The Fly
Sanofi upgraded to Buy from Hold at Deutsche Bank
15d ago
SNY
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
